Morgan Stanley Invitae Corp Transaction History

Morgan Stanley

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.42 - $0.72 $738,493 - $1.27 Million	1,758,319 New	1,758,319 $1.11 Million
Q4 2023 Feb 13, 2024	BUY	$0.42 - $0.72 $51,405 - $88,123	122,394 Added 7.48%	1,758,319 $1.11 Million
Q3 2023 Nov 15, 2023	BUY	$0.6 - $1.53 $93,729 - $239,008	156,215 Added 10.56%	1,635,925 $981,000
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $653,052 - $1.01 Million	-621,955 Reduced 29.59%	1,479,710 $1.67 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $600,331 - $1.37 Million	500,276 Added 31.24%	2,101,665 $2.84 Million
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $7.03 Million - $14.8 Million	-4,110,063 Reduced 71.96%	1,601,389 $2.98 Million
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $13.1 Million - $59.4 Million	-6,878,438 Reduced 54.63%	5,711,452 $14 Million
Q2 2022 Oct 27, 2022	BUY	$2.13 - $9.01 $24.3 Million - $103 Million	11,394,480 Added 953.19%	12,589,890 $30.7 Million
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $24.3 Million - $103 Million	11,394,480 Added 953.19%	12,589,890 $30.7 Million
Q1 2022 Oct 27, 2022	SELL	$6.28 - $15.59 $71.6 Million - $178 Million	-11,394,480 Reduced 90.51%	1,195,410 $9.53 Million
Q1 2022 May 13, 2022	SELL	$6.28 - $15.59 $1.93 Million - $4.78 Million	-306,888 Reduced 20.43%	1,195,410 $9.53 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $1.54 Million - $3 Million	104,643 Added 7.49%	1,502,298 $22.9 Million
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $34 Million - $47 Million	1,397,655 New	1,397,655 $39.7 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.